AVR 1.11% $11.55 anteris technologies ltd

Competitor - JenaValve, page-3

  1. 324 Posts.
    lightbulb Created with Sketch. 94
    http://jenavalve.com/about/

    Founded 2006
    CE mark and European availability Sep 2011

    Recently interviewed by Piper Sandler (interestingly they also spoke with Conformal Medical and 4C - Np mention of Admedus...)
    ”The company is working on a TAVR for both aortic stenosis, but more importantly, regurgitation, with more of an emphasis on the latter”.
    Clinical trial kicking off atm, potential submission late this year, possible FDA humanitarian device exemption 2021.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.